Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The urinary incontinence & pelvic organ prolapse devices and equipment market has shown strong growth in recent years. It is forecast to increase from $4.06 billion in 2025 to $4.28 billion in 2026, at a compound annual growth rate (CAGR) of 5.4%. Historically, this expansion has been driven by the rising incidence of urinary incontinence disorders, increased awareness of pelvic health conditions, greater availability of clinical treatment options, broader acceptance of medical devices for UI management, and the expansion of gynecological care services.
The urinary incontinence & pelvic organ prolapse devices and equipment market is projected for significant expansion over the coming years. It is anticipated to reach a valuation of $5.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This expansion during the forecast period is driven by factors such as the global rise in the aging population, a growing inclination towards non-invasive treatments, increased integration of home healthcare, escalating investments in women’s health technologies, and the rising need for advanced pelvic floor rehabilitation devices. Key trends expected during this period involve a greater uptake of minimally invasive treatment devices, increasing demand for non-surgical management options, wider application of electrical stimulation therapies, the proliferation of patient-centric home-use devices, and an amplified focus on comfort and biocompatibility.
Get A Free Sample Report With In-Depth Market Insights:
Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Development Factors: What’s Supporting Demand?
The expansion of the elderly demographic is anticipated to stimulate the growth of the urinary incontinence & pelvic organ prolapse devices and equipment market moving forward. This segment comprises older individuals, generally those aged 65 and above. The rise in this population is attributed to longer life expectancies, as improvements in healthcare and living standards allow people to experience healthier lives for more years. Urinary incontinence and pelvic organ prolapse are widespread health concerns within the geriatric population, necessitating various devices and equipment for their management. For instance, in October 2023, HelpAge International, a non-governmental organization dedicated to advocating for the rights of older people, projected that by 2050, 80% of the world’s older population will reside in low- and middle-income countries. This increasing elderly population is consequently driving demand in markets like urinary incontinence and pelvic organ prolapse devices.
Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Segment Analysis: What Are The Core Market Categories?
The urinary incontinence & pelvic organ prolapse devices and equipment market covered in this report is segmented –
1) By Type: Urinary Incontinence Devices, Pelvic Organ Prolapse Devices
2) By Urinary Incontinence Devices: Artificial Urinary Sphincters, Electrical Stimulation Devices, Urethral Slings, Catheters
3) By Pelvic Organ Prolapse Devices: Vaginal Mesh, Vaginal Pessary
4) By Incontinence Type: Stress Incontinence, Urge Incontinence, Overflow Incontinence, Functional Incontinence
5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Use
Subsegments:
1) By Urinary Incontinence Devices: Catheters (Intermittent, Indwelling, External), Absorbent Products (Pads, Adult Diapers), External Urinary Collection Devices, Electrical Stimulation Devices, Urethral Inserts, Artificial Urinary Sphincter
2) By Pelvic Organ Prolapse Devices: Vaginal Pessaries, Pelvic Floor Stimulation Devices, Surgical Implants, Prolapse Support Devices
Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Transformation Trends: What Innovations Are Driving Change?
Key players in the urinary incontinence and pelvic organ prolapse devices and equipment market are concentrating on technological innovation, such as patient-specific device customization, precision anatomical modeling, advanced 3D printing, and non-invasive therapeutic support solutions, to boost comfort, treatment effectiveness, and long-term pelvic floor outcomes. Patient-specific device customization allows healthcare providers to offer pessaries and support devices that precisely match the unique anatomical needs of each individual, leading to better fit, fewer complications, and a reduced need for trial-and-error fittings. For example, in March 2024, Cosm Medical, a Canada-based women’s health technology company, launched an advanced 3D-printed pessary solution called Gynethotics, created to revolutionize pelvic organ prolapse management. Utilizing detailed digital measurements of a patient’s pelvic anatomy, Gynethotics delivers custom-fitted support devices that provide superior comfort, stability, and therapeutic effectiveness compared to traditional pessaries. Dr. Bilal Iftikhar Chughtai noted that this personalized method has the capacity to considerably enhance patient satisfaction, streamline the fitting process, and decrease the requirement for invasive surgical procedures, thereby marking a significant step forward in non-surgical pelvic floor treatment.
Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the urinary incontinence & pelvic organ prolapse devices and equipment market are Boston Scientific Corporation, Coloplast A/S, Ethicon US, Becton Dickinson and Company, Johnson & Johnson, Teleflex Incorporated, Medtronic plc, COVIDien, Cook Medical, Neomedic International, CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical Inc., Thomas Medical, Kangge Medical, Dr. Arabin GmbH & Co. KG, American Medical Systems Inc., Caldera Medical Inc., Intuitive Surgical, InControl Medical LLC, Atlantic Therapeutics Ltd., Axonics Modulation Technologies, Convatec Group plc, Laborie, NUVO Group, Pelvalon, pfm medical, Promedon, Prosurg Inc., UROMED Kurt Drews KG, Verathon Inc., Vitality Medical, Women’s Choice Pharmaceuticals, Zimmer Biomet Holdings Inc.
View The Full Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Report:
Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market in 2025. Western Europe was the second-largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market report. The regions covered in the urinary incontinence & pelvic organ prolapse devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









